Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients

Psychiatry Research

Volumn 119, Issue 1-2, 2003, Pages 125-132

  Van Gool, Arthur R ^a   Fekkes, Durk ^a   Kruit, Wim H J ^a   Mulder, Paul G H ^a   Ten Hagen, Timo L M ^a   Bannink, Marjolein ^a   Maes, Michael ^b   Eggermont, Alexander M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amino acids; Biopterin; Depression; Interferon alpha; Melanoma; Neopterin; Tryptophan

Indexed keywords

ALPHA INTERFERON; AMINO ACID; BIOPTERIN; NEOPTERIN; PHENYLALANINE; TETRAHYDROBIOPTERIN; TRYPTOPHAN; TYROSINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANXIETY DISORDER; ARTICLE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; IMMUNOTHERAPY; IRRITABILITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MENTAL DISEASE; MULTICENTER STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0037966344     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(03)00113-6     Document Type: Article

References (25)

1. Bonaccorso S., Puzella A., Marino V., Pasquini M., Biondi M., Artini M., Almerighi C., Levrero M., Egyed B., Bosmans E., Meltzer H., Maes M. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase of depressive and anxiety symptoms. Psychiatry Research. 15:2001;45-55.
2. Bonaccorso S., Marino V., Puzella A., Pasquini M., Biondi M., Artini M., Almerighi C., Verkerk R., Meltzer H., Maes M. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. Journal of Clinical Psychopharmacology. 22:2002;86-90.
3. Brown R.R., Lee C.M., Kohler P.C., Hank J.A., Storer B.E., Sondel P.M. Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2. Cancer Research. 49:1989;4941-4944.
4. Brown R.R., Ozaki Y., Datta S.P., Borden E.C., Sondel P.M., Malone D.G. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune disease and AIDS. Advances in Experimental and Medical Biology. 294:1991;425-435.
5. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry. 7:2002;468-473.
6. Dieperink E., Willenbring M., Ho S.B. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. American Journal of Psychiatry. 157:2000;867-876.
7. Dunbar P.R., Hill J., Neale T.J., Mellsop G.W. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychological Medicine. 22:1992;1051-1057.
8. Dusheiko G. Side effects of alpha interferon in hepatitis C. Hepatology. 26:1997;112S-121S.
9. Fekkes D., van Dalen A., Edelman M., Voskuilen A.J. Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated derivatization with o-phtaldialdehyde. Journal of Chromatography B: Biomedical Applications. 669:1995;177-186.
10. Fernström J.D., Wurtman R.J. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 178:1972;414-416.
11. Fuchs D., Norkrans G., Wejstal R., Reibnegger G., Weiss G., Weiland O., Schvarz R., Fryden A., Wachter H. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis treated with interferon-alpha-2b. European Journal of Medicine. 1:1992;196-200.
12. Fukushima T., Nixon J.C. Analysis of reduced forms of biopterin in biological tissues and fluids. Analytical Biochemistry. 102:1980;176-180.
13. Hashimoto R., Ozaki N., Ohta T., Kasahara Y., Kaneda N., Nagatsu T. Plasma tetrahydrobiopterin levels in patients with psychiatric disorders. Neuropsychobiology. 23:1990;140-143.
14. Hashimoto R., Mizutani M., Ohta T., Nakazawa K., Nagatsu T. Changes in plasma tetrahydrobiopterin levels of depressives in depressive and remission phases: reconfirmed by measurement with an internal standard. Neuropsychobiology. 29:1994;57-60.
15. Hoekstra R., van den Broek W.W., Fekkes D., Bruijn J.A., Mulder P.G.M., Pepplinkhuizen L. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe medication-resistent depression. Psychiatry Research. 103:2001;115-123.
16. Liberati A.M., Horisberger M.A., Garofani P., De Angelis V., Ferrajoli A., Di Clemente F., Caricchi P., Adiuto D., Fedeli L., Palumbo B. Interferon-alpha-induced biological modifications in patients with chronic myelogenous leukemia. Journal of Interferon Research. 14:1994;349-355.
17. Maes M., Meltzer H.Y., Scharpé S., Bosmans E., Suy, De Meester I., Calabrese J., Cosyns P. Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Research. 49:1993;151-165.
18. Maes M. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 20:1995;111-116.
19. Maes M., Wauters A., Verkerk R., Demedts P., Neels H., Van Gastel A., Cosyns P., Scharpé S., Desnyder R. Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacology. 15:1996;243-251.
20. Maes M. The immune pathophysiology of major depression. Honig A., van Praag H.M. Depression: Neurobiological, Psychopathological and Therapeutic Advances. 1997;197-215 Wiley, Chichester, UK.
21. Maes M. Major depression and activation of the immune system. Dantzer R., Wollman E.E., Yirmiya R. Cytokines, Stress and Depression. 1999;25-46 Kluwer Academic/Plenum Publishers, New York.
22. Menkes D.B., MacDonald J.A. Interferons, serotonin and neurotoxicity. Psychological Medicine. 30:2000;259-268.
23. Taylor M., Feng G. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase and tryptophan metabolism. FASEB Journal. 5:1991;2516-2522.
24. Thony B., Auerbach G., Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochemical Journal. 347:2000;1-16.
25. Van Amsterdam J.G.C., Opperhuizen A. Nitric oxide and biopterin in depression and stress. Psychiatry Research. 85:1999;33-38.